NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE236304 Query DataSets for GSE236304
Status Public on Jan 01, 2024
Title MethNet: a robust approach to identify regulatory hubs and their distal targets in cancer [Perturb-seq]
Organism Homo sapiens
Experiment type Other
Summary We present MethNet, a pipeline that integrates large-scale DNA methylation and gene expression data across multiple cancers, to uncover novel cis regulatory elements (CREs) in a 1Mb region around every promoter in the genome. MethNet identifies highly ranked CREs, referred to as ‘hubs’, which contribute to the regulation of multiple genes and strongly affect patient survival. Promoter-capture Hi-C confirmed that highly ranked associations involve physical interactions between CREs and their gene targets, and CRISPRi based scRNA Perturb-seq validated the functional impact of CREs. Thus, MethNet represents a valuable resource for unraveling complex mechanisms underlying gene expression, and for prioritizing the verification of predicted non-coding disease hotspots.
 
Overall design CloneTracker XP CRISPR Barcode pooled lentiviral libraries expressing barcoded sgRNAs, the puromycin selection gene as well as an RFP reporter were purchased from Cellecta®. The A549 cells were transduced with lentiviruses expressing dCas9-KRAB-MECP2 plasmids as described in Yeo et al. Cells were then grown in DMEM medium (Gibco/Invitrogen) + 10% FBS + 100 units/ml penicillin + 100 μg/ml streptomycin + 5% CO2 at 37℃. The 248 sgRNAs targeting high-confidence MethNet hubs and 5 non-targeting sgRNAs (negative controls) were designed using CRISPick for the Human GRCh37 (hg19) assembly using parameter settings: CRISPRi, SpyoCas9/Chen (2013) tracrRNA (Suppl. Table 1). The lentiviral libraries were transduced into the A549-dCAS9-KRAB-MeCP2 cells according to Cellecta® protocols. Briefly, 105 cells/well were seeded into a 6 well-plate. The optimal MOI of viral particles (to reach ~30-40% of infected cells) were added. On day 3, 2 ug/ml of puromycin was added, resulting in >90% transduced cell selection as confirmed by cytofluorometry using RFP (Figure S7). Cells were expanded under puromycin selection until day 14. For scRNA-seq using the 10X Genomics technology, 25,000 cells were harvested. For optimal multiplet detection and optimal signal-to-noise ratios, cells were hashtagged using 5 cell multiplexing oligos purchased from 10X Genomics. The sequencing library was, then, prepared using the Chromium Next GEM Single Cell 3ʹ Kit according to the manufacturer’s protocol and sequenced by NYU Langone's Genome Technology Center.
 
Contributor(s) Sakellaropoulos T, Jiang G, Meyn P, Heguy A, Tsirigos A, Do C, Skok J
Citation(s) 37577603, 39025865
Submission date Jun 30, 2023
Last update date Aug 09, 2024
Contact name Theodoros Sakellaropoulos
E-mail(s) theodoros.sakellaropoulos@nyulangone.org
Organization name NYU Langone
Street address 550 1st Avenue
City New York
ZIP/Postal code 10016
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (3)
GSM7527832 A549-dcas9-RFP-Pool_S9
GSM7527833 A549-dcas9-RFP-Pool-HT
GSM7527834 A549-dcas9-RFP-Pool-CRISPR_S17
This SubSeries is part of SuperSeries:
GSE236305 MethNet: a robust approach to identify regulatory hubs and their distal targets in cancer
Relations
BioProject PRJNA989650

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE236304_barcodes.tsv.gz 117.6 Kb (ftp)(http) TSV
GSE236304_feature_reference.csv.gz 4.5 Kb (ftp)(http) CSV
GSE236304_features.tsv.gz 328.5 Kb (ftp)(http) TSV
GSE236304_filtered_feature_bc_matrix.h5 193.0 Mb (ftp)(http) H5
GSE236304_matrix.mtx.gz 535.5 Mb (ftp)(http) MTX
GSE236304_protospacer_umi_thresholds.csv.gz 1.4 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap